Tetanus Trials in Salt Lake City, United States
Conditions / Tetanus / Salt Lake City, United States
Research into Tetanus spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00346073 | Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years | COMPLETED | PHASE3 |
| NCT01738477 | Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults | COMPLETED | PHASE3 |
| NCT00355121 | Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® | COMPLETED | PHASE2 |
| NCT02587520 | Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects | COMPLETED | PHASE1/PHASE2 |
| NCT00489970 | Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 | COMPLETED | PHASE3 |
| NCT00282295 | US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease | COMPLETED | PHASE4 |
| NCT00457249 | A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older | COMPLETED | PHASE4 |
| NCT01311557 | Study of Adacel® Vaccine Administered to Persons 10 Years of Age | COMPLETED | PHASE4 |
| NCT02096263 | Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants | COMPLETED | PHASE3 |
| NCT00109330 | A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine | COMPLETED | PHASE3 |